EUDA Health Holdings Limited (EUDA) - Kapitalizatsiyaning foydaga nisbati

euda.com (EUDA) korporativ emblemasi va logotipi

Janubiy-Sharqiy Osiyoda kengayishning sekinlashishi xavflari va yo'qotishlar tufayli likvidlik tanqisligi EUDA Health (EUDA) o'sishini cheklamoqda. Biroq, kompaniya klinikalarni o'z ekotizimiga chuqur integratsiya qilish orqali texnologik gigantlar uchun to'siqlar yaratmoqda. GURU.Markets platformasidagi -148.50 metrikasiga ega ushbu narxlar grafigi aktivning dinamikasini aniq ko'rsatadi. Biznes bulutli tibbiy ma'lumotlar uzatishiga tayanadi, bu esa transport xarajatlarini yo'qotadi va xizmat ko'rsatish sifatini oshiradi.

EUDA Health Holdings - EUDA Narx-foyda koeffitsiyenti (davr: 28.04.2023 - 10.11.2026)

EUDA Health (EUDA) kompaniyasining tahliliy kesimlari

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Kompaniyaning jamlanma tahlili:EUDA Health Holdings EUDA
EUDA Health original mahsuloti

Janubi-Sharqiy Osiyoning tartibga soluvchi tizimlari fragmentatsiyasi sharoitida telemeditsina dasturiy ta'minotini ishlab chiqayotgan EUDA Health uchun kompaniyaning P/E koeffitsiyenti diapazoni biznesning bozor qiymatini uning haqiqiy daromadlariga nisbatan ko'rsatuvchi indikator vazifasini o'taydi. Ushbu koeffitsiyent joriy aksiya narxining umumiy yillik foydaga nisbati sifatida hisoblanadi, bu esa investorlarga aktivning haddan tashqari qimmat baholanganlik darajasini aniqlash va "qiymat tuzog'i" xatarlarini o'z vaqtida tan olish imkonini beradi.

Muhim raqobatchilar

Narx-foyda koeffitsiyenti HCA Holdings (HCA)|P/E multiplikatori THC|FMS - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Solventum Inc. SOLV|EHC: Narx-foyda multiplikatori|UHS: Narx-foyda koeffitsiyenti|davita.com - Bozor narxining sof foydaga nisbati|RDNT: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Option Care (OPCH)|Narx-foyda koeffitsiyenti SGRY|P/E multiplikatori Premier Health|P/E multiplikatori EYE|progyny.com - Narx-foyda multiplikatori|P/E multiplikatori ARDT (Ardent Health Partners)|P/E multiplikatori Select Medical Corporation SEM|ASTH: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati MD (Pediatrix Medical)|USPH: P/E multiplikatori|pennantgroup.com - Kompaniya qiymatining sof foydaga nisbati|ORGO (Organogenesis) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Nutex Health Inc NUTX|P/E multiplikatori AUNA|P/E multiplikatori SBC Medical Group Inc (SBC)|Narxning foydaga nisbati Evolus, Inc. EOLS|chs.net - Narxning foydaga nisbati|SKIN: Narx-foyda koeffitsiyenti|MediWound Ltd. - Bozor narxining sof foydaga nisbati|BTMD: P/E multiplikatori|The Joint - Kompaniya qiymatining sof foydaga nisbati|DCGO (DocGo Inc.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati P3 Health PIII|Narx-foyda koeffitsiyenti GANX (Gain Therapeutics)|P/E multiplikatori baselmedical.com (BMGL)|P/E multiplikatori CLGN (CollPlant Biotechnologies Ltd.)|CUPR: Narx-foyda multiplikatori|Concord Medical Services - P/E multiplikatori|AMS - P/E multiplikatori|MRM (MEDIROM Healthcare Group) - Narx-foyda koeffitsiyenti|ALBT: Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati DIH Holding US Inc.|XAGE: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori NIVF|ATIP - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori CMAX (CareMax)|P/E multiplikatori Kindly MD Inc KDLY|MODV: Narx-foyda koeffitsiyenti|Novo Integrated Sciences Corp - Bozor narxining sof foydaga nisbati|sunlinkhealth.com (SSY) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti imacholdings.comm